Scholars Central

Conference abstractPublished 12 Nov 2013

Supplier management - Key components of managing suppliers in a cGMP environment

Authors: Pejman Parhami

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

FDA holds pharmaceutical companies liable for introducing or causing the introduction into interstate commerce of adulterated or misbranded products. FDA Safety and Innovation Act explains that GMPs include owner?s ?implementation of oversight and controls over the manufacture of drugs to ensure quality, including managing the risk of and establishing the safety of raw materials used in the manufacturing of drugs, and finished drug products.? Additionally, new draft guidance on quality agreements, describes the responsibilities of drug manufacturers with respect to oversight of their suppliers. The seminar is a discussion of supplier management covering topics such as vendor qualification, supplier assessment, quality audits, supplier performance, and quality agreements.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Pejman Parhami”